BioCryst Pharmaceuticals BCRX Effective Income Tax Rate Reconciliation, Tax Credit, Expiration Of Research And Development Tax Credits, Amount
Effective Income Tax Rate Reconciliation, Tax Credit, Expiration Of Research And Development Tax Credits, Amount at other companies
Other financials
Where this comes from
Reported directly by BioCryst Pharmaceuticals in its filing.
Tagged under the XBRL concept bcrx:EffectiveIncomeTaxRateReconciliationTaxCreditExpirationOfResearchAndDevelopmentTaxCreditsAmount.
The official record: BioCryst Pharmaceuticals’s 10-K, filed February 26, 2026, on SEC EDGAR. View the filing →
Ask your AI about BioCryst Pharmaceuticals's effective income tax rate reconciliation, tax credit, expiration of research and development tax credits, amount.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is BioCryst Pharmaceuticals's effective income tax rate reconciliation, tax credit, expiration of research and development tax credits, amount?
- BioCryst Pharmaceuticals (BCRX) reported effective income tax rate reconciliation, tax credit, expiration of research and development tax credits, amount of -$893.5K in Q4 2025.
- How has BioCryst Pharmaceuticals's effective income tax rate reconciliation, tax credit, expiration of research and development tax credits, amount changed year-over-year?
- BioCryst Pharmaceuticals's effective income tax rate reconciliation, tax credit, expiration of research and development tax credits, amount decreased by 42.2% year-over-year, from -$628.5K to -$893.5K.
- What is the long-term trend for BioCryst Pharmaceuticals's effective income tax rate reconciliation, tax credit, expiration of research and development tax credits, amount?
- Over 2 years (2023 to 2025), BioCryst Pharmaceuticals's effective income tax rate reconciliation, tax credit, expiration of research and development tax credits, amount has grown at a 107.4% compound annual growth rate (CAGR), from -$831K to -$3.57M.
- What does effective income tax rate reconciliation, tax credit, expiration of research and development tax credits, amount mean?
- The financial impact of the expiration of previously recognized research and development tax credits that were not utilized within the statutory timeframe. This metric highlights potential inefficiencies in tax planning or the inability to fully monetize R&D tax incentives.